Eslicarbazepine acetate - Epilepsy
You are here : Home > Formulary Search > Eslicarbazepine acetate - Epilepsy
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Guidelines (National)
Shared Care
Shared Care
PAD Profile
ChemicalSubstance :
Eslicarbazepine acetate
Indication :
Epilepsy
Group Name :
Keywords :
Brand Names Include :
Zebinix
Important Information :
Only when 1st-line and 1st-line adjunctive agents have been unsuccessful
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
6
Other Indications
Below are listed other indications that Eslicarbazepine acetate is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Epilepsy.
- Brivaracetam
- Cannabis (medicinal)
- Carbamazepine
- Cenobamate
- Clobazam
- Clonazepam
- Ethosuximide
- Gabapentin
- Lacosamide
- Lamotrigine
- Levetiracetam
- Oxcarbazepine
- Perampanel
- Phenobarbital
- Phenytoin
- Pregabalin
- Primidone
- Rufinamide
- Sodium valproate (NON childbearing potential)
- Sodium valproate (with childbearing potential)
- Stiripentol
- Sulthiame
- Tiagabine
- Topiramate
- Vigabatrin
- Zonisamide
Committee Recommendations (2)
The PCN supported the principles of switching from brand to generic medications (not recommended in the elderly) as per national guidelines in September 2013 and the proposed place in therapy of the anti-epileptic drugs which is based on NICE guidance was also discussed at that time. Shared Care supported in November 2014 are attached below. Please note the MHRA categorisations for each drug in the attached guidance (updated January 2014) and in the link below.
20 Feb 13 -
Epsom St Helier NDAIG
Shared care documentation approved